Returns | 1W : -0.6% , 1M : -6%,1Y : 11.8% |
LT :   |
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : Average |
ST :   |
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Peers & Returns | 1W | 1M | 1Y |
INDOCO REMEDIES LTD | -0.6% | -6% | 11.8% |
SUN PHARMACEUTICAL INDUSTRIES LTD | -0.1% | 5.5% | 56.9% |
DR REDDYS LABORATORIES LTD | -0.8% | -9.3% | 44.9% |
DIVIS LABORATORIES LTD | -3.6% | -1.7% | 62.4% |
CIPLA LTD | -0.8% | -6.5% | 90.2% |
BIOCON LTD | -1.9% | 2.6% | 30.9% |
AUROBINDO PHARMA LTD | -0.4% | -9.5% | 71.2% |
LUPIN LTD | 2.3% | -3% | 53% |
TORRENT PHARMACEUTICALS LTD | -0.5% | -8.8% | 11.5% |
Ratio | Value |
---|---|
P/E P/B P/S |
110.97
P/E Calculated based on EPS of 2.63
[ Mar2020 - Standalone Results ] 3.95
P/B Calculated based on Book Value of 73.81
[ Mar2020 - Standalone Results ] 2.38
P/S Calculated based on Revenues of 1129.19 Cr
[ TTM - Standalone Results ] |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
210% 70% 40% |
Pledged Shares |
0 % |
---|---|
As on : Sep2020 | |
If less than 25% | Good |
If between 25% and 50% | Neutral |
If greater than 50% | Bad |